Evidence map›Paper›PMID 40924042›Full record

ArticleStem cell reviews and reports2025

Dual Role of DLK1 in GnRH Neuron Ontogeny.

Nazli Eskici, Celia Gomez-Sanchez, Shrinidhi Madhusudan, Kristiina Pulli, Salla Keskitalo, Tanja Turunen, Kirsi Vaaralahti, Yafei Wang, Markku Varjosalo, Taneli Raivio

Abstract read
In one paragraph

Article in Stem cell reviews and reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nazli EskiciStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland. nazli.eskici@helsinki.fi.ORCID 0000-0003-0460-0700
Celia Gomez-SanchezStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Shrinidhi MadhusudanStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Kristiina PulliStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Salla KeskitaloInstitute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.
Tanja TurunenInstitute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.
Kirsi VaaralahtiStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Yafei WangStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Markku VarjosaloInstitute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.
Taneli RaivioStem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland. taneli.raivio@helsinki.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in Delta Like Non-Canonical Notch Ligand 1 (DLK1), a paternally expressed imprinted gene, underlie central precocious puberty (CPP), yet the mechanism remains unclear. To test the hypothesis that DLK1 plays a role in gonadotropin releasing hormone (GnRH) neuron ontogeny, 75 base pairs were deleted in both alleles of DLK1 exon 3 with CRISPR-Cas9 in human pluripotent stem cells (hPSCs). This line, exhibiting More than 80% loss of DLK1 protein, was differentiated into GnRH neurons by dual SMAD inhibition (dSMADi), FGF8 treatment and Notch inhibition, as previously described, however, it did not exhibit accelerated GNRH1 expression. Activation of (WT) DLK1 with CRISPRa during dSMADi suppressed the formation of anterior neuronal precursors, and almost completely inhibited GnRH neuron fate. Instead, it induced the expression of Wnt pathway genes, markers of proliferating and non-proliferating neuronal progenitors, and dorsal spinal cord interneurons. Activation of DLK1 expression, during the FGF8 phase, significantly increased GNRH1 expression and secretion of GnRH decapeptide. In conclusion, significant loss of DLK1 protein did not accelerate GNRH1 expression, suggesting that CPP caused by paternally inherited loss-of-function mutations is due to mechanisms acting up- or downstream of GnRH neurons. Conversely, timing of DLK1 activation emerged as an important factor in determining GnRH neuron fate, with early expression disrupting GnRH lineage commitment and later activation enhancing GNRH1 expression.

Indexed as

Calcium-Binding ProteinsGonadotropin-Releasing HormoneNeuronsCell DifferentiationFibroblast Growth Factor 8HumansMembrane ProteinsPluripotent Stem CellsWnt Signaling PathwayCalcium-Binding ProteinsDLK1 protein, humanFibroblast Growth Factor 8Gonadotropin-Releasing HormoneMembrane ProteinsCRISPR activationDLK1GnRH neuronsNeural differentiation

Identifiers

PMID40924042
PMCPMC12504412

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.